4th Annual MarketsandMarkets Epigenetics Congress to Host Speakers from GSK, 4SC, Oryzon, Karus, and AstraZeneca


Posted July 2, 2019 by MnMConferences

Discussing solutions to challenges like, drug discovery, identification of molecular inhibitors, gene modification and analysis our 4th Annual MarketsandMarkets Epigenetics Congress will take place on 3-4 October in Radisson Blu Edwardian, Grafton.

 
London, July 2 – MarketsandMarkets presents to you the 4th Annual MarketsandMarkets Epigenetics Congress to be held on 3 - 4 October 2019 in London, UK. This 2-day event will host more than 25+ expert speakers, 15+ sponsors, 120+ professionals working on epigenetics, developmental epigenetics, epidemiology, molecular biology, genetics and genomics and translational sciences.

The congress will focus on discussing epigenetics solutions, challenges and insights associated with drug discovery, identification of molecular inhibitors, gene modification, gene analysis and advancement in epigenetics research with a special emphasis on transcriptional analysis and molecular profiling.

The conference will be attended by leading pharma/biopharma companies and academia working on Epigenetics, Developmental Epigenetics, Epidemiology, Molecular Biology, Developmental Biology, Biochemistry, Genetics and Genomics and Translational Sciences. The congress will serve as a unique platform to witness epigenetics based clinical development and combinational therapies.

Speaker organizations such as GSK, 4SC, Oryzon, Karus, AstraZeneca, University of Groningen, Novartis Institute of Biomedical Research, Rodin Therapeutics, NARCIS, University of Oxford, Imperial College will share industry insights associated with epigenetics drug discovery.

Here’s some of the key presentations to look forward to at this event;

Gavin Reynolds, Professor Emeritus, Queen’s University Belfast, UK will present on topic - DNA methylation as an epigenetic factor in psychiatric disorders and their treatment; Christopher Schofield, Head of Organic Chemistry, University of Oxford, UK will present on challenges in targeting histone demethylases; Alfredo Budillon, Chief Experimental Pharmacology Unit Department of Research, Istituto Nazionale Tumori, Italy will speak on development of novel therapeutic anticancer approach with HDAC inhibitors; and Ronan Murphy, Associate Editor, Clinical Epigenetic, Dublin City University, Ireland presenting on Platelets: Functional biomarkers of epigenetic drift.

The event overview, registration details and complete speaker list are available on the official website. You can also download the complete agenda to identify the potential interest in the conference on this page – https://bit.ly/2URGDJU or you can directly email on [email protected] asking for more details, your queries and provide feedback.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By MarketsandMarkets Conferences
Phone 2048598285
Business Address GV4C+XW Westminster, London, UK
Country United States
Categories Health , Research , Science
Last Updated July 2, 2019